TY - JOUR
T1 - High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India
AU - Gupta, Amita
AU - Anand, Shuchi
AU - Sastry, Jayagowri
AU - Krisagar, Anandini
AU - Basavaraj, Anita
AU - Bhat, Shreepad M.
AU - Gupte, Nikhil
AU - Bollinger, Robert C.
AU - Kakrani, Arjun L.
N1 - Funding Information:
We thank all the medical research officers of the maternal-infant transmission trial and hospital staff that made this study possible. None of the authors have any conflicts of interest to disclose. This study was supported by a grant from the US National Institutes of Health (NIH, NIAID) (R01 AI45462) as well as in part by a fellowship/grant from the Fogarty International Center/USNIH: Grant # 2 D 43 TW000010-20-AITRP and was undertaken in collaboration with Byramji Jeejeebhoy Medical College (BJMC) in Pune, India. The views expressed in this manuscript do not necessarily represent the views of BJMC, NIH, Fogarty International Centre, or the Johns Hopkins University.
PY - 2008/10/21
Y1 - 2008/10/21
N2 - Background: The risk for occupational exposure to HIV has been well characterized in the developed world, but limited information is available about this transmission risk in resource-constrained settings facing the largest burden of HIV infection. In addition, the feasibility and utilization of post-exposure prophylaxis (PEP) programs in these settings are unclear. Therefore, we examined the rate and characteristics of occupational exposure to HIV and the utilization of PEP among health care workers (HCW) in a large, urban government teaching hospital in Pune, India. Methods: Demographic and clinical data on occupational exposures and their management were prospectively collected from January 2003-December 2005. US Centers for Diseases Control guidelines were utilized to define risk exposures, for which PEP was recommended. Incidence rates of reported exposures and trends in PEP utilization were examined using logistic regression. Results: Of 1955 HCW, 557 exposures were reported by 484 HCW with an incidence of 9.5 exposures per 100 person-years (PY). Housestaff, particularly interns, reported the greatest number of exposures with an annual incidence of 47.0 per 100 PY. Personal protective equipment (PPE) was used in only 55.1% of these exposures. The incidence of high-risk exposures was 6.8/100 PY (n = 339); 49.1% occurred during a procedure or disposing of equipment and 265 (80.0%) received a stat dose of PEP. After excluding cases in which the source tested HIV negative, 48.4% of high-risk cases began an extended PEP regimen, of whom only 49.5% completed it. There were no HIV or Hepatitis B seroconversions identified. Extended PEP was continued unnecessarily in 7 (35%) of 20 cases who were confirmed to be HIV-negative. Over time, there was a significant reduction in proportion of percutaneous exposures and high-risk exposures (p < 0.01) and an increase in PEP utilization for high risk exposures (44% in 2003 to 100% in 2005, p = 0.002). Conclusion: Housestaff are a vulnerable population at high risk for bloodborne exposures in teaching hospital settings in India. With implementation of a hospital-wide PEP program, there was an encouraging decrease of high-risk exposures over time and appropriate use of PEP. However, overall use of PPE was low, suggesting further measures are needed to prevent occupational exposures in India.
AB - Background: The risk for occupational exposure to HIV has been well characterized in the developed world, but limited information is available about this transmission risk in resource-constrained settings facing the largest burden of HIV infection. In addition, the feasibility and utilization of post-exposure prophylaxis (PEP) programs in these settings are unclear. Therefore, we examined the rate and characteristics of occupational exposure to HIV and the utilization of PEP among health care workers (HCW) in a large, urban government teaching hospital in Pune, India. Methods: Demographic and clinical data on occupational exposures and their management were prospectively collected from January 2003-December 2005. US Centers for Diseases Control guidelines were utilized to define risk exposures, for which PEP was recommended. Incidence rates of reported exposures and trends in PEP utilization were examined using logistic regression. Results: Of 1955 HCW, 557 exposures were reported by 484 HCW with an incidence of 9.5 exposures per 100 person-years (PY). Housestaff, particularly interns, reported the greatest number of exposures with an annual incidence of 47.0 per 100 PY. Personal protective equipment (PPE) was used in only 55.1% of these exposures. The incidence of high-risk exposures was 6.8/100 PY (n = 339); 49.1% occurred during a procedure or disposing of equipment and 265 (80.0%) received a stat dose of PEP. After excluding cases in which the source tested HIV negative, 48.4% of high-risk cases began an extended PEP regimen, of whom only 49.5% completed it. There were no HIV or Hepatitis B seroconversions identified. Extended PEP was continued unnecessarily in 7 (35%) of 20 cases who were confirmed to be HIV-negative. Over time, there was a significant reduction in proportion of percutaneous exposures and high-risk exposures (p < 0.01) and an increase in PEP utilization for high risk exposures (44% in 2003 to 100% in 2005, p = 0.002). Conclusion: Housestaff are a vulnerable population at high risk for bloodborne exposures in teaching hospital settings in India. With implementation of a hospital-wide PEP program, there was an encouraging decrease of high-risk exposures over time and appropriate use of PEP. However, overall use of PPE was low, suggesting further measures are needed to prevent occupational exposures in India.
UR - http://www.scopus.com/inward/record.url?scp=57149128591&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=57149128591&partnerID=8YFLogxK
U2 - 10.1186/1471-2334-8-142
DO - 10.1186/1471-2334-8-142
M3 - Article
C2 - 18939992
AN - SCOPUS:57149128591
SN - 1471-2334
VL - 8
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
M1 - 142
ER -